Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
American Journal of Translational Research
|
April 12, 2019
Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta
Renuka P Limgala, Tabitha Jennelle, Matthew Plassmeyer, et al.
Frontiers in Allergy
|
June 16, 2025
Enhancing allergy diagnosis: mass spectrometry as a complementary technique to the basophil activation test
Nicole Wheeler, Miloslav Sanda, Lanya Rasool, et al.
The Journal of Rheumatology
|
June 1, 2022
Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody-Positive Patients with Livedo
Ecem Sevim, Salma Siddique, Madhavi Latha S Chalasani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 3, 2024
STAT4 Phosphorylation of T-helper Cells predicts surgical outcomes in Refractory Chronic Rhinosinusitis
Michael R Abidin, Oral Alpan, Matthew Plassmeyer, et al.
Annals of Internal Medicine
|
May 4, 2011
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial
Nicola A Hanania, Oral Alpan, Daniel L Hamilos, et al.
The Journal of Investigative Dermatology
|
July 22, 2014
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study
Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, et al.
The Journal of Investigative Dermatology
|
December 16, 2014
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, et al.
Plos One
|
March 20, 2015
A pilot study of omalizumab in eosinophilic esophagitis
Denise Loizou, Benjamin Enav, Edina Komlodi-Pasztor, et al.
Clinical and Translational Allergy
|
July 18, 2022
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)
Stanley J Szefler, Graham Roberts, Adalberto S Rubin, et al.
The Journal of Allergy and Clinical Immunology
|
September 18, 2014
Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis
Marc E Rothenberg, Ting Wen, Allison Greenberg, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
American Journal of Translational Research
|
April 12, 2019
Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta
Renuka P Limgala, Tabitha Jennelle, Matthew Plassmeyer, et al.
Frontiers in Allergy
|
June 16, 2025
Enhancing allergy diagnosis: mass spectrometry as a complementary technique to the basophil activation test
Nicole Wheeler, Miloslav Sanda, Lanya Rasool, et al.
The Journal of Rheumatology
|
June 1, 2022
Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody-Positive Patients with Livedo
Ecem Sevim, Salma Siddique, Madhavi Latha S Chalasani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 3, 2024
STAT4 Phosphorylation of T-helper Cells predicts surgical outcomes in Refractory Chronic Rhinosinusitis
Michael R Abidin, Oral Alpan, Matthew Plassmeyer, et al.
Annals of Internal Medicine
|
May 4, 2011
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial
Nicola A Hanania, Oral Alpan, Daniel L Hamilos, et al.
The Journal of Investigative Dermatology
|
July 22, 2014
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study
Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, et al.
The Journal of Investigative Dermatology
|
December 16, 2014
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, et al.
Plos One
|
March 20, 2015
A pilot study of omalizumab in eosinophilic esophagitis
Denise Loizou, Benjamin Enav, Edina Komlodi-Pasztor, et al.
Clinical and Translational Allergy
|
July 18, 2022
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)
Stanley J Szefler, Graham Roberts, Adalberto S Rubin, et al.
The Journal of Allergy and Clinical Immunology
|
September 18, 2014
Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis
Marc E Rothenberg, Ting Wen, Allison Greenberg, et al.
Page
of 4